nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—ALB—focal segmental glomerulosclerosis	0.307	1	CbGaD
Diclofenac—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.142	0.353	CbGbCtD
Diclofenac—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0771	0.191	CbGbCtD
Diclofenac—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0508	0.126	CbGbCtD
Diclofenac—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0426	0.106	CbGbCtD
Diclofenac—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0354	0.0878	CbGbCtD
Diclofenac—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0344	0.0852	CbGbCtD
Diclofenac—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0206	0.0511	CbGbCtD
Diclofenac—SLC22A8—nephron—focal segmental glomerulosclerosis	0.00627	0.11	CbGeAlD
Diclofenac—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0251	CcSEcCtD
Diclofenac—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0245	CcSEcCtD
Diclofenac—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0245	CcSEcCtD
Diclofenac—PTGS2—nephron—focal segmental glomerulosclerosis	0.00356	0.0625	CbGeAlD
Diclofenac—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.0238	CcSEcCtD
Diclofenac—Atrophy—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.0227	CcSEcCtD
Diclofenac—CXCL8—nephron tubule—focal segmental glomerulosclerosis	0.0029	0.0509	CbGeAlD
Diclofenac—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.0187	CcSEcCtD
Diclofenac—PLA2G2A—kidney—focal segmental glomerulosclerosis	0.00257	0.0452	CbGeAlD
Diclofenac—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.0174	CcSEcCtD
Diclofenac—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0168	CcSEcCtD
Diclofenac—SLC22A11—nephron tubule—focal segmental glomerulosclerosis	0.0024	0.0422	CbGeAlD
Diclofenac—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00226	0.0397	CbGeAlD
Diclofenac—SLCO1C1—kidney—focal segmental glomerulosclerosis	0.00217	0.0381	CbGeAlD
Diclofenac—UGT2B7—kidney—focal segmental glomerulosclerosis	0.00216	0.038	CbGeAlD
Diclofenac—SLC22A11—kidney—focal segmental glomerulosclerosis	0.00211	0.037	CbGeAlD
Diclofenac—SLC22A11—cortex of kidney—focal segmental glomerulosclerosis	0.00205	0.0361	CbGeAlD
Diclofenac—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.0139	CcSEcCtD
Diclofenac—SCN4A—kidney—focal segmental glomerulosclerosis	0.002	0.0351	CbGeAlD
Diclofenac—TTR—kidney—focal segmental glomerulosclerosis	0.00194	0.0341	CbGeAlD
Diclofenac—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00194	0.034	CbGeAlD
Diclofenac—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0126	CcSEcCtD
Diclofenac—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0126	CcSEcCtD
Diclofenac—UGT1A1—kidney—focal segmental glomerulosclerosis	0.00184	0.0323	CbGeAlD
Diclofenac—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00175	0.0308	CbGeAlD
Diclofenac—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0115	CcSEcCtD
Diclofenac—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0114	CcSEcCtD
Diclofenac—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00168	0.0295	CbGeAlD
Diclofenac—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.011	CcSEcCtD
Diclofenac—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0106	CcSEcCtD
Diclofenac—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00949	CcSEcCtD
Diclofenac—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00941	CcSEcCtD
Diclofenac—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00941	CcSEcCtD
Diclofenac—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.00136	0.024	CbGeAlD
Diclofenac—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00919	CcSEcCtD
Diclofenac—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.00135	0.0238	CbGeAlD
Diclofenac—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00912	CcSEcCtD
Diclofenac—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00878	CcSEcCtD
Diclofenac—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00865	CcSEcCtD
Diclofenac—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00853	CcSEcCtD
Diclofenac—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00841	CcSEcCtD
Diclofenac—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00823	CcSEcCtD
Diclofenac—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00818	CcSEcCtD
Diclofenac—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00818	CcSEcCtD
Diclofenac—ABCC4—kidney—focal segmental glomerulosclerosis	0.0012	0.0211	CbGeAlD
Diclofenac—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00812	CcSEcCtD
Diclofenac—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00812	CcSEcCtD
Diclofenac—SLC22A8—kidney—focal segmental glomerulosclerosis	0.00119	0.0209	CbGeAlD
Diclofenac—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00801	CcSEcCtD
Diclofenac—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00801	CcSEcCtD
Diclofenac—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00801	CcSEcCtD
Diclofenac—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00796	CcSEcCtD
Diclofenac—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00117	0.0205	CbGeAlD
Diclofenac—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00791	CcSEcCtD
Diclofenac—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.00116	0.0204	CbGeAlD
Diclofenac—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00776	CcSEcCtD
Diclofenac—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00776	CcSEcCtD
Diclofenac—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00776	CcSEcCtD
Diclofenac—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00739	CcSEcCtD
Diclofenac—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00726	CcSEcCtD
Diclofenac—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00713	CcSEcCtD
Diclofenac—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00701	CcSEcCtD
Diclofenac—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00678	CcSEcCtD
Diclofenac—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.000996	0.0175	CbGeAlD
Diclofenac—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.00675	CcSEcCtD
Diclofenac—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.00675	CcSEcCtD
Diclofenac—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000984	0.00668	CcSEcCtD
Diclofenac—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00095	0.00644	CcSEcCtD
Diclofenac—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.00641	CcSEcCtD
Diclofenac—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.00641	CcSEcCtD
Diclofenac—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000926	0.00628	CcSEcCtD
Diclofenac—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000904	0.00613	CcSEcCtD
Diclofenac—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.0009	0.00611	CcSEcCtD
Diclofenac—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.00605	CcSEcCtD
Diclofenac—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.000889	0.0156	CbGeAlD
Diclofenac—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.00599	CcSEcCtD
Diclofenac—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.00599	CcSEcCtD
Diclofenac—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.00599	CcSEcCtD
Diclofenac—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.00597	CcSEcCtD
Diclofenac—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.00597	CcSEcCtD
Diclofenac—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000875	0.00594	CcSEcCtD
Diclofenac—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000871	0.0153	CbGeAlD
Diclofenac—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00086	0.00583	CcSEcCtD
Diclofenac—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.000834	0.0147	CbGeAlD
Diclofenac—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000834	0.00566	CcSEcCtD
Diclofenac—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00083	0.00563	CcSEcCtD
Diclofenac—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000827	0.00561	CcSEcCtD
Diclofenac—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00082	0.00556	CcSEcCtD
Diclofenac—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000817	0.00554	CcSEcCtD
Diclofenac—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000813	0.00552	CcSEcCtD
Diclofenac—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.00549	CcSEcCtD
Diclofenac—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00081	0.00549	CcSEcCtD
Diclofenac—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000806	0.00547	CcSEcCtD
Diclofenac—CYP1A1—kidney—focal segmental glomerulosclerosis	0.000804	0.0141	CbGeAlD
Diclofenac—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00079	0.00536	CcSEcCtD
Diclofenac—CYP2B6—kidney—focal segmental glomerulosclerosis	0.000781	0.0137	CbGeAlD
Diclofenac—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000778	0.00528	CcSEcCtD
Diclofenac—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00074	0.00502	CcSEcCtD
Diclofenac—CYP2E1—kidney—focal segmental glomerulosclerosis	0.000733	0.0129	CbGeAlD
Diclofenac—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000724	0.00491	CcSEcCtD
Diclofenac—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000722	0.0049	CcSEcCtD
Diclofenac—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.000714	0.0125	CbGeAlD
Diclofenac—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.00483	CcSEcCtD
Diclofenac—PTGS1—kidney—focal segmental glomerulosclerosis	0.000706	0.0124	CbGeAlD
Diclofenac—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000699	0.00474	CcSEcCtD
Diclofenac—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.00473	CcSEcCtD
Diclofenac—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.00466	CcSEcCtD
Diclofenac—PTGS2—kidney—focal segmental glomerulosclerosis	0.000675	0.0119	CbGeAlD
Diclofenac—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000672	0.00456	CcSEcCtD
Diclofenac—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00067	0.00454	CcSEcCtD
Diclofenac—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000665	0.00451	CcSEcCtD
Diclofenac—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.00446	CcSEcCtD
Diclofenac—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.00444	CcSEcCtD
Diclofenac—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000639	0.00433	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000635	0.00431	CcSEcCtD
Diclofenac—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000631	0.00428	CcSEcCtD
Diclofenac—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00422	CcSEcCtD
Diclofenac—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000618	0.00419	CcSEcCtD
Diclofenac—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000616	0.00418	CcSEcCtD
Diclofenac—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000613	0.00416	CcSEcCtD
Diclofenac—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.00413	CcSEcCtD
Diclofenac—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.00413	CcSEcCtD
Diclofenac—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.00412	CcSEcCtD
Diclofenac—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.00407	CcSEcCtD
Diclofenac—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00406	CcSEcCtD
Diclofenac—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00405	CcSEcCtD
Diclofenac—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00405	CcSEcCtD
Diclofenac—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00403	CcSEcCtD
Diclofenac—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00403	CcSEcCtD
Diclofenac—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000592	0.00402	CcSEcCtD
Diclofenac—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000592	0.00402	CcSEcCtD
Diclofenac—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00059	0.0104	CbGeAlD
Diclofenac—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.00394	CcSEcCtD
Diclofenac—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.00391	CcSEcCtD
Diclofenac—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000574	0.0039	CcSEcCtD
Diclofenac—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00388	CcSEcCtD
Diclofenac—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00055	0.00373	CcSEcCtD
Diclofenac—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000548	0.00372	CcSEcCtD
Diclofenac—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00371	CcSEcCtD
Diclofenac—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00371	CcSEcCtD
Diclofenac—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.00369	CcSEcCtD
Diclofenac—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000543	0.00368	CcSEcCtD
Diclofenac—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.00366	CcSEcCtD
Diclofenac—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000536	0.00364	CcSEcCtD
Diclofenac—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000527	0.00357	CcSEcCtD
Diclofenac—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00346	CcSEcCtD
Diclofenac—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.00344	CcSEcCtD
Diclofenac—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000496	0.00337	CcSEcCtD
Diclofenac—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00334	CcSEcCtD
Diclofenac—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000491	0.00333	CcSEcCtD
Diclofenac—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00331	CcSEcCtD
Diclofenac—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00328	CcSEcCtD
Diclofenac—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00325	CcSEcCtD
Diclofenac—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000476	0.00323	CcSEcCtD
Diclofenac—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000475	0.00834	CbGeAlD
Diclofenac—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000469	0.00318	CcSEcCtD
Diclofenac—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000467	0.00317	CcSEcCtD
Diclofenac—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000466	0.00316	CcSEcCtD
Diclofenac—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000462	0.00314	CcSEcCtD
Diclofenac—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.0031	CcSEcCtD
Diclofenac—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000449	0.00304	CcSEcCtD
Diclofenac—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000446	0.00302	CcSEcCtD
Diclofenac—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.003	CcSEcCtD
Diclofenac—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.00298	CcSEcCtD
Diclofenac—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000437	0.00297	CcSEcCtD
Diclofenac—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00295	CcSEcCtD
Diclofenac—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000429	0.00291	CcSEcCtD
Diclofenac—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.0029	CcSEcCtD
Diclofenac—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000426	0.00289	CcSEcCtD
Diclofenac—ABCB1—kidney—focal segmental glomerulosclerosis	0.000418	0.00733	CbGeAlD
Diclofenac—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00282	CcSEcCtD
Diclofenac—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.0028	CcSEcCtD
Diclofenac—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00279	CcSEcCtD
Diclofenac—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000407	0.00714	CbGeAlD
Diclofenac—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00275	CcSEcCtD
Diclofenac—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00275	CcSEcCtD
Diclofenac—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00275	CcSEcCtD
Diclofenac—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.00274	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.00273	CcSEcCtD
Diclofenac—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0004	0.00272	CcSEcCtD
Diclofenac—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00269	CcSEcCtD
Diclofenac—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.00266	CcSEcCtD
Diclofenac—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.00264	CcSEcCtD
Diclofenac—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.00264	CcSEcCtD
Diclofenac—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.00262	CcSEcCtD
Diclofenac—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000381	0.00258	CcSEcCtD
Diclofenac—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00038	0.00258	CcSEcCtD
Diclofenac—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000377	0.00256	CcSEcCtD
Diclofenac—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000376	0.00255	CcSEcCtD
Diclofenac—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.00251	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.0024	CcSEcCtD
Diclofenac—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00238	CcSEcCtD
Diclofenac—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000349	0.00237	CcSEcCtD
Diclofenac—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000346	0.00235	CcSEcCtD
Diclofenac—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.00234	CcSEcCtD
Diclofenac—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.00232	CcSEcCtD
Diclofenac—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.00229	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00227	CcSEcCtD
Diclofenac—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00227	CcSEcCtD
Diclofenac—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00225	CcSEcCtD
Diclofenac—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00225	CcSEcCtD
Diclofenac—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00032	0.00217	CcSEcCtD
Diclofenac—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00215	CcSEcCtD
Diclofenac—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.00209	CcSEcCtD
Diclofenac—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00208	CcSEcCtD
Diclofenac—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00208	CcSEcCtD
Diclofenac—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00194	CcSEcCtD
Diclofenac—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.00189	CcSEcCtD
Diclofenac—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00186	CcSEcCtD
Diclofenac—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000266	0.0018	CcSEcCtD
Diclofenac—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.00174	CcSEcCtD
Diclofenac—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00168	CcSEcCtD
Diclofenac—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.00166	CcSEcCtD
Diclofenac—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.00166	CcSEcCtD
Diclofenac—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000243	0.00165	CcSEcCtD
Diclofenac—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.00157	CcSEcCtD
Diclofenac—CXCR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.8e-05	0.000791	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.79e-05	0.000791	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.75e-05	0.000786	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.69e-05	0.000778	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	6.61e-05	0.000769	CbGpPWpGaD
Diclofenac—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.54e-05	0.000762	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.46e-05	0.000752	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.38e-05	0.000743	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—LIPC—focal segmental glomerulosclerosis	6.29e-05	0.000732	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.25e-05	0.000728	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.13e-05	0.000713	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.98e-05	0.000696	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.95e-05	0.000692	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	5.85e-05	0.000681	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.76e-05	0.000671	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	5.76e-05	0.000671	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	5.76e-05	0.000671	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.72e-05	0.000666	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.68e-05	0.000661	CbGpPWpGaD
Diclofenac—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	5.67e-05	0.000661	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.66e-05	0.000659	CbGpPWpGaD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	5.66e-05	0.000659	CbGpPWpGaD
Diclofenac—UGT1A1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	5.65e-05	0.000658	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.59e-05	0.000651	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CTGF—focal segmental glomerulosclerosis	5.54e-05	0.000645	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.45e-05	0.000635	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.39e-05	0.000628	CbGpPWpGaD
Diclofenac—TTR—Disease—LPL—focal segmental glomerulosclerosis	5.37e-05	0.000625	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	5.3e-05	0.000617	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.29e-05	0.000616	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	5.26e-05	0.000613	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—LPL—focal segmental glomerulosclerosis	5.23e-05	0.000609	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	5.22e-05	0.000607	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.19e-05	0.000604	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.1e-05	0.000594	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	5.01e-05	0.000583	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5e-05	0.000582	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.86e-05	0.000566	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.85e-05	0.000564	CbGpPWpGaD
Diclofenac—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	4.79e-05	0.000558	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.78e-05	0.000557	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	4.69e-05	0.000547	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	4.68e-05	0.000545	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	4.61e-05	0.000536	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.57e-05	0.000532	CbGpPWpGaD
Diclofenac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	4.56e-05	0.000531	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	4.55e-05	0.00053	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.53e-05	0.000527	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AGT—focal segmental glomerulosclerosis	4.47e-05	0.000521	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.42e-05	0.000515	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.42e-05	0.000514	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.4e-05	0.000512	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.37e-05	0.000508	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	4.34e-05	0.000505	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.32e-05	0.000502	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.28e-05	0.000498	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	4.24e-05	0.000494	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—LIPC—focal segmental glomerulosclerosis	4.23e-05	0.000493	CbGpPWpGaD
Diclofenac—TTR—Disease—NOS2—focal segmental glomerulosclerosis	4.2e-05	0.000488	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	4.19e-05	0.000488	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	4.12e-05	0.000479	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	4.04e-05	0.000471	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.02e-05	0.000468	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.01e-05	0.000467	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.99e-05	0.000464	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.96e-05	0.000461	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.93e-05	0.000458	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	3.92e-05	0.000457	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.88e-05	0.000451	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—LPL—focal segmental glomerulosclerosis	3.84e-05	0.000447	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	3.83e-05	0.000446	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	3.83e-05	0.000445	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.8e-05	0.000442	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.78e-05	0.00044	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.76e-05	0.000438	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.74e-05	0.000435	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CTGF—focal segmental glomerulosclerosis	3.73e-05	0.000434	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.68e-05	0.000428	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.65e-05	0.000425	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.63e-05	0.000423	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.63e-05	0.000422	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.56e-05	0.000415	CbGpPWpGaD
Diclofenac—TTR—Disease—SERPINE1—focal segmental glomerulosclerosis	3.53e-05	0.000411	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.53e-05	0.000411	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	3.51e-05	0.000408	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.48e-05	0.000406	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.46e-05	0.000403	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.45e-05	0.000402	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—ALB—focal segmental glomerulosclerosis	3.43e-05	0.0004	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.43e-05	0.0004	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	3.37e-05	0.000392	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.35e-05	0.00039	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.35e-05	0.00039	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.34e-05	0.000389	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.31e-05	0.000386	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AGT—focal segmental glomerulosclerosis	3.28e-05	0.000382	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.23e-05	0.000376	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.22e-05	0.000375	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.22e-05	0.000375	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.2e-05	0.000372	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.18e-05	0.00037	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.11e-05	0.000362	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.07e-05	0.000357	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.97e-05	0.000346	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.97e-05	0.000345	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.95e-05	0.000344	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.95e-05	0.000343	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.9e-05	0.000338	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.88e-05	0.000336	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.84e-05	0.000331	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.84e-05	0.00033	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.82e-05	0.000328	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.76e-05	0.000321	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.75e-05	0.00032	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.73e-05	0.000318	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.71e-05	0.000316	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.63e-05	0.000307	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.62e-05	0.000305	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.6e-05	0.000303	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—LPL—focal segmental glomerulosclerosis	2.58e-05	0.000301	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.54e-05	0.000296	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.52e-05	0.000294	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ALB—focal segmental glomerulosclerosis	2.52e-05	0.000293	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	2.51e-05	0.000293	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.47e-05	0.000288	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.45e-05	0.000286	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.42e-05	0.000282	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.42e-05	0.000282	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.41e-05	0.000281	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.4e-05	0.00028	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.4e-05	0.00028	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.39e-05	0.000278	CbGpPWpGaD
Diclofenac—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	2.35e-05	0.000274	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.32e-05	0.00027	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.25e-05	0.000262	CbGpPWpGaD
Diclofenac—TTR—Disease—TGFB1—focal segmental glomerulosclerosis	2.23e-05	0.00026	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.21e-05	0.000258	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AGT—focal segmental glomerulosclerosis	2.21e-05	0.000257	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.17e-05	0.000252	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.16e-05	0.000251	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.16e-05	0.000251	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	2.15e-05	0.00025	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.12e-05	0.000247	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.09e-05	0.000244	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	2.08e-05	0.000243	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.08e-05	0.000242	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.07e-05	0.00024	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.06e-05	0.00024	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.05e-05	0.000239	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	2.04e-05	0.000238	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.04e-05	0.000237	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.99e-05	0.000232	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	1.97e-05	0.000229	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.97e-05	0.000229	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.95e-05	0.000227	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.92e-05	0.000224	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.91e-05	0.000222	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.89e-05	0.000221	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000215	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	1.84e-05	0.000214	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.83e-05	0.000213	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.79e-05	0.000209	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	1.76e-05	0.000205	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.76e-05	0.000205	CbGpPWpGaD
Diclofenac—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	1.75e-05	0.000204	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.75e-05	0.000203	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.73e-05	0.000202	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.73e-05	0.000201	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ALB—focal segmental glomerulosclerosis	1.7e-05	0.000197	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.69e-05	0.000197	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.69e-05	0.000197	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	1.68e-05	0.000196	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.68e-05	0.000196	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.68e-05	0.000196	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	1.66e-05	0.000194	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.66e-05	0.000193	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.65e-05	0.000193	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	1.65e-05	0.000192	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.59e-05	0.000185	CbGpPWpGaD
Diclofenac—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	1.58e-05	0.000184	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	1.57e-05	0.000183	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.56e-05	0.000182	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.56e-05	0.000182	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.55e-05	0.000181	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	1.55e-05	0.00018	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	1.54e-05	0.00018	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.54e-05	0.000179	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.44e-05	0.000167	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.43e-05	0.000167	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.43e-05	0.000166	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.42e-05	0.000166	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.42e-05	0.000165	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.41e-05	0.000165	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	1.38e-05	0.000161	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.35e-05	0.000157	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.34e-05	0.000156	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	1.32e-05	0.000154	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.31e-05	0.000153	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	1.29e-05	0.000151	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.29e-05	0.00015	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.28e-05	0.000149	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.27e-05	0.000148	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	1.27e-05	0.000148	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.26e-05	0.000147	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.25e-05	0.000145	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	1.24e-05	0.000145	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	1.23e-05	0.000144	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.23e-05	0.000143	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.17e-05	0.000137	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.16e-05	0.000135	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	1.13e-05	0.000132	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.1e-05	0.000128	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.1e-05	0.000127	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.09e-05	0.000127	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	1.09e-05	0.000127	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.08e-05	0.000126	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.08e-05	0.000125	CbGpPWpGaD
Diclofenac—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	1.07e-05	0.000124	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	1.06e-05	0.000124	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.05e-05	0.000122	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	1.04e-05	0.000121	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1e-05	0.000117	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.94e-06	0.000116	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	9.76e-06	0.000114	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	9.6e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	9.46e-06	0.00011	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	9.37e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	9.2e-06	0.000107	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	9.15e-06	0.000106	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	8.75e-06	0.000102	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	8.68e-06	0.000101	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	8.34e-06	9.71e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	8.33e-06	9.69e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	8.21e-06	9.56e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	8.17e-06	9.51e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	8.01e-06	9.33e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	7.7e-06	8.97e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.67e-06	8.93e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	7.49e-06	8.72e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	7.48e-06	8.71e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	7.06e-06	8.22e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	6.55e-06	7.63e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	6.4e-06	7.45e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	6.3e-06	7.34e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	6.15e-06	7.16e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	5.77e-06	6.72e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	5.75e-06	6.69e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	4.94e-06	5.75e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	4.91e-06	5.72e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	3.79e-06	4.41e-05	CbGpPWpGaD
